AU2002257857A1 - Association of a tumor antigen and a system for delivering a cytokine or a chemokine for cancer immunotherapy purposes - Google Patents

Association of a tumor antigen and a system for delivering a cytokine or a chemokine for cancer immunotherapy purposes

Info

Publication number
AU2002257857A1
AU2002257857A1 AU2002257857A AU2002257857A AU2002257857A1 AU 2002257857 A1 AU2002257857 A1 AU 2002257857A1 AU 2002257857 A AU2002257857 A AU 2002257857A AU 2002257857 A AU2002257857 A AU 2002257857A AU 2002257857 A1 AU2002257857 A1 AU 2002257857A1
Authority
AU
Australia
Prior art keywords
chemokine
cytokine
delivering
association
tumor antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002257857A
Inventor
Pascal Chaux
Joel Crouzet
Marina Ostankovitch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NEUROTECH
Original Assignee
NEUROTECH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NEUROTECH filed Critical NEUROTECH
Publication of AU2002257857A1 publication Critical patent/AU2002257857A1/en
Abandoned legal-status Critical Current

Links

AU2002257857A 2001-04-03 2002-04-03 Association of a tumor antigen and a system for delivering a cytokine or a chemokine for cancer immunotherapy purposes Abandoned AU2002257857A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR01/04538 2001-04-03

Publications (1)

Publication Number Publication Date
AU2002257857A1 true AU2002257857A1 (en) 2002-10-21

Family

ID=

Similar Documents

Publication Publication Date Title
IL125608A0 (en) Tumor associated antigen peptides and use of same as anti-tumor vaccines
AU2002332290A1 (en) Recombinant anti-osteopontin antibody and use thereof
HUP0400284A3 (en) Recombinant tumor specific antibody and use thereof
AU2003235707A1 (en) Immunogenic preparations and vaccines on the basis of mrna
AU2003256912A1 (en) Tumor associated antigen, peptides thereof, and use of same as anti-tumor vaccines
AUPR894201A0 (en) Respiratory delivery for gene therapy and lentiviral delivery particle
AU4139801A (en) Controlled delivery of antigens
AU2002244968A1 (en) Anti-osteopontin antibody and use thereof
IL164897A0 (en) Fusions of cytokines and tumor targeting proteins
IL201751A (en) Il-17 like cytokine binding compound and antibodies
AU2001294834A1 (en) Recombinant bcg vaccines for the prevention and treatment of cancer
AU2637100A (en) Delivery system and methods for gene therapy
WO2001061017A3 (en) Modified cytokines for use in cancer therapy
AU2002349543A1 (en) Tumor antigens
AU2002361559A1 (en) Anticancer vaccine and diganostic methods and reagents
AU2457701A (en) Methods and products for tumor immunotherapy using cytokines
AU2002257033A1 (en) Agents and methods for the prevention of initial onset and recurrence of existing cancers
AU2002356898A1 (en) Gene amplification and overexpression in cancer
AU2002313426A1 (en) Tumor antigens for prevention and/or treatment of cancer
PL356770A1 (en) Use of anti-idiotypical antibodies as vaccines against cancer
AU2001284122A1 (en) Vaccines against cytokines and growth factors derived from malignant tumours
AU2002257857A1 (en) Association of a tumor antigen and a system for delivering a cytokine or a chemokine for cancer immunotherapy purposes
EP1316560A4 (en) Novel human cancer/testis antigen and gene thereof
AU2002322066A1 (en) N-terminally truncated galectin-3 and antibodies for treating cancer
AU2002227272A1 (en) Ovarian tumor antigen and methods of use therefor